PROMETIC ENTERS INTO COMMERCIAL AND STRATEGIC INVESTMENT AGREEMENTS TOTALLING $21 MILLION WITH SHENZHEN HEPALINK PHARMACEUTICAL CO., LTD

October 16, 2012
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2012
X